Shyamala Navada

Search results

• Findings from Icahn School of Medicine at Mount Sinai Yields New Findings on Acute Myeloid Leukemia (Ascertaining Quazars: Slow-motion and Light-speed Development of Oral Azacitidine and Decitabine)

  Douglas Tremblay, Shyamala Navada & Lewis Silverman

  13/12/22

  1 item of Media coverage

  Press/Media

• Onconova Announces Five Presentations on Rigosertib in Myelodysplastic Syndromes (MDS) at the ASH 2019 Annual Meeting & Exposition

  Shyamala Navada

  7/11/19

  8 items of Media coverage

  Press/Media

• Onconova Announces Five Presentations on Rigosertib in Myelodysplastic Syndromes (MDS) at the ASH 2019 Annual Meeting & Exposition

  Shyamala Navada

  7/11/19

  2 items of Media coverage

  Press/Media

• Five Presentations on Rigosertib in Myelodysplastic Syndromes (MDS) at the ASH 2019 Annual Meeting &Exposition

  Shyamala Navada

  7/11/19

  2 items of Media coverage

  Press/Media

• Onconova Announces Five Presentations on Rigosertib in Myelodysplastic Syndromes (MDS) at the ASH 2019 Annual Meeting & Exposition

  Shyamala Navada

  7/11/19

  1 item of Media coverage

  Press/Media

• Addition of Rigosertib Improves Azacitidine Benefit In Patients With Higher-Risk MDS

  Shyamala Navada

  16/06/19

  1 item of Media coverage

  Press/Media

• Onconova Therapeutics Announces Presentations at the 24th Congress of the European Hematology Association

  Shyamala Navada & Lewis Silverman

  10/06/19

  1 item of Media coverage

  Press/Media

• Onconova Therapeutics Announces Presentations at the 24th Congress of the European Hematology Association

  Shyamala Navada & Lewis Silverman

  10/06/19

  2 items of Media coverage

  Press/Media

• Onconova Therapeutics Announces Presentations at the 24th Congress of the European Hematology Association

  Shyamala Navada & Lewis Silverman

  10/06/19

  1 item of Media coverage

  Press/Media

• Presentations at the 24th Congress of the European Hematology Association

  Shyamala Navada & Lewis Silverman

  10/06/19

  1 item of Media coverage

  Press/Media

• Onconova Therapeutics Announces Presentations at the#16024th Congress of the European Hematology Association Nasdaq:ONTX

  Shyamala Navada & Lewis Silverman

  10/06/19

  1 item of Media coverage

  Press/Media

• Onconova Therapeutics Announces Presentations at the 24th Congress of the European Hematology Association

  Shyamala Navada & Lewis Silverman

  10/06/19

  1 item of Media coverage

  Press/Media

• Onconova Therapeutics Announces Presentations at the 24th Congress of the European Hematology Association

  Shyamala Navada & Lewis Silverman

  10/06/19

  1 item of Media coverage

  Press/Media

• Onconova Therapeutics Announces Presentations at the 24th Congress of the European Hematology Association

  Shyamala Navada & Lewis Silverman

  10/06/19

  1 item of Media coverage

  Press/Media

• Presentations at the 24th Congress of the European Hematology Association

  Shyamala Navada & Lewis Silverman

  10/06/19

  1 item of Media coverage

  Press/Media

• Onconova Therapeutics Announces Presentations at the 24th Congress of the European Hematology Association

  Shyamala Navada & Lewis Silverman

  9/06/19 → 10/06/19

  8 items of Media coverage

  Press/Media

• Onconova Therapeutics Announces Presentations at the 24th Congress of the European ...

  Shyamala Navada & Lewis Silverman

  10/06/19

  1 item of Media coverage

  Press/Media

• Onconova Therapeutics Announces Presentations at the 24th Congress of the European Hematology Association

  Shyamala Navada & Lewis Silverman

  10/06/19

  1 item of Media coverage

  Press/Media

• Onconova Therapeutics Announces Presentations at the 24th Congress of the European Hematology Association

  Shyamala Navada & Lewis Silverman

  10/06/19

  1 item of Media coverage

  Press/Media